Twinlab launches liver detox formulated for athletes

GRAND RAPIDS, Mich. Twinlab on Friday announced the launch of Liver D-Tox Fuel, a daily liver detoxifying formula that combines L-glutathione and alpha lipoic acid along with an exclusive Purification Matrix formula.

Designed with athletes in mind, Liver D-Tox is made with natural ingredients and contains no harsh chemicals that interfere with the natural detoxification process.

“Most people would benefit from a detoxifying product, but athletes have additional needs,” stated Thane Slagowski, Twinlab director of research and development. “Not only do they introduce more free radicals into their system through intense exercise, but the additional stresses they put on their body also increase the toxins in their system, making their liver work even harder.”

TRENDING STORIES

Amerifit launches trio of brand Web sites

CROMWELL, Conn. Amerifit Brands on Monday announced the Web site launches of three of its top consumer health brands: Estroven.com, Culturelle.com and AzoProducts.com.

“We have made significant improvements to the websites of three Amerifit Brands companies with new features and capabilities that we believe will serve as valuable resources to consumers looking to maintain and improve their health,” stated Cyrill Siewert, chief executive officer of Amerifit Brands.

Estroven.com offers perimenopausal and menopausal women (ages 40–60) an updated platform where they can find women’s health and menopause-related information. Women are encouraged to visit the website’s unique Lifestyle Lounge, where they can read and share stories and jokes about menopause.

Culturelle.com appeals to adults, parents and travelers looking to supplement their immune and digestive systems. The site features individually designed sections for these targets.

TRENDING STORIES

FDA seizes over $300,000 of product from General Theraputics

ROCKVILLE, Md. The Food and Drug Administration on Wednesday directed the seizure of more than $300,000 worth of product, including NC Solution, an antifungal product, and other drugs for human or animal use, dietary supplements and the ingredients to make those products because some lacked FDA approval and all were maintained under what the FDA defined as “grossly unsanitary conditions” by General Therapeutics of St. Louis, Mo.

“The action taken Wednesday is the culmination of the concerted efforts by the FDA to get the firm to follow the law when it comes to manufacturing safe products for consumers,” stated Margaret Glavin, FDA associate commissioner for regulatory affairs.

The FDA considers NC Solution to be a drug because it is intended for the use in the diagnosis, cure, or treatment of disease in people or animals. NC Solution is also a new drug because it is not generally recognized as safe and effective for its intended uses.

In August and September, FDA inspectors found that the company was still manufacturing drugs and dietary supplements under unsanitary conditions, including insects and rodent filth on and around manufacturing equipment, despite a warning by FDA of serious violations in 1999. Following the 1999 inspection, a company official told the FDA in January, 2000, it would stop manufacturing drugs.

The FDA recommends that consumers who have any products manufactured by General Therapeutics, including NC Solution, consult their health care providers about discontinuing use and if they have experienced any adverse events that they suspect are related to the product’s use.

Catherine Hanaway, U.S. attorney for the Eastern District of Missouri, filed the complaint requesting the seizure, and her office will continue to coordinate with the FDA to ensure proper disposal of the seized items.

CRN’s new assistant general counsel most recently held the position of special counsel for Wiley Rein in Washington. Prior to that position, she spent more than two years as senior counsel at Walgreens.

Forgotten Password

Registration complete

REGISTER

USERNAME *

Spaces are allowed; punctuation is not allowed except for periods, hyphens, and underscores.

E-MAIL ADDRESS *

A valid e-mail address. All e-mails from the system will be sent to this address. The e-mail address is not made public and will only be used if you wish to receive a new password or wish to receive certain news or notifications by e-mail.

Password *

Confirm Password *

Please choose a password for your account; it must be 8 - 30 characters. .

First Name *

Last Name *

Company Name *

Job Title *

ZIP *

Are you a *

Retailer or Healthcare professional

Non-Retailer

How many stores do you operate?: *

Which best describes the business/industry you work in?: *

Which best describes your job title?: *

Please select the newsletters you would like to subscribe to

DSN A.M.
Daily news stories covering the retail drug industry

Breaking News
First-to-the-market with developing stories in the industry